Urinary System pp 375-381 | Cite as

Carcinogenesis, Urinary Tract, Rat

  • Shoji Fukushima
Part of the Monographs on Pathology of Laboratory Animals book series (LABORATORY)


Animal models are very useful for studying the pathogenesis of human disease. Experimental chemical carcinogenesis in the urinary tract has long attracted attention, with the main focus on the urinary bladder resulting in a number of animal models. This paper covers recent advances in carcinogenesis in the experimental urinary tract, especially in the urinary bladder.


Urinary Bladder Transitional Cell Carcinoma Butylate Hydroxy Anisole Urinary Bladder Carcinoma Bladder Carcinogenesis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Cohen SM, Jacobs UB, Arai M, Johansson S, Friedell GH (1976) Early lesions in experimental bladder cancer: experimental design and light microscopic findings. Cancer Res 362:508–2511Google Scholar
  2. Cohen SM, Arai M, Jacobs JB, Friedell GH (1979) Promoting effect of saccharin and DL-tryptophan in urinary bladder carcinogenesis. Cancer Res 39:1207–1217PubMedGoogle Scholar
  3. Croft W A, Bryan GT (1973) Production of urinary bladder carcinomas in male hamsters by N-[4-(5-nitro-2-furyl)-2- thiazolyl] formamide, N-[4-(5-nitro-2-furyl)-2-thiazolyl] acetamide, or formic acid 2-[4-(5-nitro-2-furyl)-2- thiazolyl] hydrazide. J Natl Cancer Inst 51:941–949PubMedGoogle Scholar
  4. Druckrey H, Preussman R, Ivankovic S, Schmidt CH, Mennel HD, Stahl KW (1964) Selektive Erzeugung von Blasenkrebs an Ratten durch Dibutyl-und N-Butyl-Nbutanol(4)-nitrosamin. Z Krebsforsch 66:280–290PubMedCrossRefGoogle Scholar
  5. Ertiirk E, Cohen SM, Price JM, Bryan GT (1969) Pathogenesis, histology, and transplantability of urinary bladder carcinomas induced in albino rats by oral administration of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide. Cancer Res 29:2219–2228Google Scholar
  6. Fukushima S (1991) Modification of tumor development in the urinary bladder. In: Ito N, Sugano H (eds) Progress in experimental tumor research. Karger, Basel, pp 154–174Google Scholar
  7. Fukushima S, Murasaki G, Hirose M, Nakanishi K, Hasegawa R, Ito N (1982) Histopathological analysis of preneoplastic changes during N-butyl-N-(4- hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in rats. Acta Pat hoi Jpn 32:242–250Google Scholar
  8. Fukushima S, Kurata Y, Shibata M, Ikawa E, Ito N (1984) Promotion by ascorbic acid, sodium erythorbate and ethoxyquin of neoplastic lesions in rats initiated with Nbutyl- N-(4-hydroxybutyl)nitrosamine. Cancer Lett 23:29–37PubMedCrossRefGoogle Scholar
  9. Fukushima S, Shibata M, Shirai T, Tamano S, Ito N (1986) Roles of urinary sodium ion concentration and pH in promotion by ascorbic acid of urinary bladder carcinogenesis in rats. Cancer Res 46:1623–1626PubMedGoogle Scholar
  10. Hashimoto Y, Suzuki E, Okada M (1972) Induction of urinary bladder tumors in ACI-N rats by butyl(3- carboxypropyl) nitrosoamine, a major urinary metabolite of butyl(4-hydroxybutyl)nitrosoamine. Gann 63: 637–638PubMedGoogle Scholar
  11. Hicks RM, Wakefield J St J (1972) Rapid induction of bladder cancer in rats with N-methyl-N-nitrosourea. 1. Histology. Chern Bioi Interact 5:139–152CrossRefGoogle Scholar
  12. Hicks RN, Wakefield J St J, Chowaniec J (1975) Evaluation of a new model to detect bladder carcinogens or cocarcinogens: results obtained with saccharin, cyclamate and cyclophosphamide. Chern Bioi Interact 11:225–233CrossRefGoogle Scholar
  13. Hirose M, Fukushima S, Hananouchi M, Shirai T, Ogiso T, Takahashi M, Ito N (1976) Different susceptibilities of the urinary bladder epithelium of animal species to three nitroso compounds. Gann 67:175–189PubMedGoogle Scholar
  14. Imaida K, Fukushima S, Shirai T, Ohtani M, Nakanishi K, Ito N (1983) Promoting activities of butylated hydroxyanisole and butylated hydroxy toluene on 2-stage urinary bladder carcinogenesis and inhibition of gammaglutamyl transpeptidase-positive foci development in the liver of rats. Carcinogenesis 4:895–899PubMedCrossRefGoogle Scholar
  15. Ito N, Hiasa Y, Tarnai A, Okajima E, Kitamura H (1969) Histogenesis of urinary bladder tumors induced by Nbutyl- N-(4-hydroxybutyl)nitrosamine in rats. Gann 60:401–410PubMedGoogle Scholar
  16. Ito N, Makiura S, Yokota Y, Kamamoto Y, Hiasa Y, Sugihara S (1971) Effect of unilateral ureter ligation on development of tumors in the urinary system of rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Gann 62:359–365PubMedGoogle Scholar
  17. Ketkar MB, Preussman R, Mohr U (1984) The carcinogenic effect of bis-(2-oxopropyl)nitrosamine on Sprague-Dawley rat. Cancer Lett 2:473–79Google Scholar
  18. Maekawa A, Mtuoka C, Onodera H, Tanigawa H, Furuta K, Ogio T, Mitsumori K, Hayashi Y (1985) Organ-specific carcinogenicity of N-methyl-N-nitrosourea in F344 and ACIIN rats. Cancer Res Clin Oncol 109:178–182CrossRefGoogle Scholar
  19. Mori S, Hosono M, Machino S, Nakai S, Makino S, Nakao H, Takeuchi Y, Takeda R, Mural T, Fukushima S (1994) Induction of renal pelvic and ureteral carcinomas by Nbutyl- N-(4-hydroxybutyl)nitrosamine in SD/cShi rats with spontaneous hydronephrosis. Toxicol Pathol 22:373–380PubMedCrossRefGoogle Scholar
  20. Nakanishi K, Hagiwara A, Shibata M, Imaida K, Tatematsu M, Ito N (1980) Dose-response of saccharin in induction of urinary bladder hyperplasias in Fischer 344 rats pretreated with N-butyl-N-(4-hydroxybutyl) nitrosamine. J Natl Cancer Inst 65:1005–1010PubMedGoogle Scholar
  21. Nishio Y, Kakizoe T, Ohtani M, Sato S, Sugimura T, Fukushima S (1986) L-Isoleucine and L-leucine: tumor promoters of bladder cancer in rats. Science 231:843–845PubMedCrossRefGoogle Scholar
  22. Ohtani M, Fukushima S, Okamura T, Sakata T, Ito N, Koiso K, Niijim T (1984) Effects of intravesical instillation of antitumor chemotherapeutic agents on bladder carcinogenesis in rats treated with N-butyl-N-(4- hydroxybutyl)nitrosamine. Cancer 54:1525–1529PubMedCrossRefGoogle Scholar
  23. Okada M, Suzuki EM. Mochizuki M (1976) Possible important role of urinary N-methyl-N-(3- carboxypropyl)nitrosamine in the induction of bladder tumors in rats by N-methyl-N-dodecylnitrosamine. Gann 67:771–772PubMedGoogle Scholar
  24. Okajima E, Hiramatsu T, Hirao K. ljuin M, Hirao Y, Babaya K, Ikuma S, Ohara S, Shiomi T, Hijioka T. Ohishi H (1981) Urinary bladder tumors induced by Nbutyl- N-(4-hydroxybutyl)nitrosaminc in dogs. Cancer Res 41:1958–1966PubMedGoogle Scholar
  25. Oyasu R, Hirao Y, Izumi K (1981) Enhancement by urine of urinary bladder carcinogenesis. Cancer Res 41:478–481PubMedGoogle Scholar
  26. Shirai T. Tagawa Y, Fukushima S, Imaida K, Ito N (1987) Strong promoting activity of reversible uracil-induced urolithiasis on urinary bladder carcinogenesis in rats initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Cancer Res 47:6726–6730PubMedGoogle Scholar
  27. Takahashi M, Toyoda K, Aze Y, Furuta K, Mitsumori K, Hayashi Y (1993) The rat urinary bladder as a new target of heterocyclic amine carcinogenicity: tumor induction by 3-amino-l-methyl-5H-pyrido[4, 3-b]lindole acetate. Jpn J Cancer Res 84:852–858PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1998

Authors and Affiliations

  • Shoji Fukushima

There are no affiliations available

Personalised recommendations